Lv6
1978 积分 2025-03-04 加入
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations
8天前
已完结
Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database
1个月前
已完结
Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape
2个月前
已完结
Structural and Physicochemical Features of Oral PROTACs
2个月前
已完结
Correction to "Closing the Design-Make-Test-Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability"
3个月前
已完结
Property-Based Prediction Uncovers Intestinal Excretion as an Elimination Route of Small-Molecule Drugs
4个月前
已完结
Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles
4个月前
已完结
Calculating safety margins using total plasma concentration versus unbound plasma concentration - does it make a difference?
4个月前
已关闭
Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability
4个月前
已完结
Correction to "Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Guidelines on Model Fitting and Recommendations on Time Course for In Vitro CYP Induction Studies Including Impact on Drug Interaction Risk Assessment"
4个月前
已完结
皖公网安备34019202002308
